Upstream Bio, Inc. (UPB) — Financial Flexibility Index
Upstream Bio, Inc. (UPB) has a Financial Flexibility Index of -3.49x as of June 2026. Free cash flow of $-35.62 Million (operating CF $-35.62 Million minus capex $0.00) represents -3% of total liabilities ($10.21 Million). Check UPB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Upstream Bio, Inc. Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Upstream Bio, Inc. across 4 annual periods. For the full cash flow conversion analysis, see UPB cash flow conversion.
Annual Financial Flexibility Index for Upstream Bio, Inc. (2022–2025)
Year-by-year free cash flow to debt coverage for Upstream Bio, Inc.. Explore debt repayment capacity of Upstream Bio, Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.51x | $-133.11 Million | $-133.28 Million | $14.00 Million | ▼ -92.3% |
| 2024 | -4.94x | $-58.66 Million | $-59.17 Million | $11.87 Million | ▼ -3044.3% |
| 2023 | -0.16x | $-37.78 Million | $-37.93 Million | $240.32 Million | ▼ -3.5% |
| 2022 | -0.15x | $-18.94 Million | $-19.02 Million | $124.63 Million | — |